Cargando…
Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients
BACKGROUND: The aggressive biology of cancers arising in adolescent and young adult (AYA; ages 15–39 years) patients is thought to contribute to poor survival outcomes. METHODS: We used clinical next-generation sequencing (NGS) results to examine the molecular alterations and diverse biology of canc...
Autores principales: | Subbiah, Vivek, Bupathi, Manojkumar, Kato, Shumei, Livingston, Andrew, Slopis, John, Anderson, Pete M., Hong, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549362/ https://www.ncbi.nlm.nih.gov/pubmed/26328274 |
Ejemplares similares
-
Analysis of MDM2 Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies
por: Kato, Shumei, et al.
Publicado: (2018) -
Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives
por: Bupathi, Manojkumar, et al.
Publicado: (2014) -
Theranostic profiling for actionable aberrations in advanced high risk osteosarcoma with aggressive biology reveals high molecular diversity: the human fingerprint hypothesis
por: Egas-Bejar, Daniela, et al.
Publicado: (2014) -
Next generation sequencing of carcinoma of unknown primary reveals novel combinatorial strategies in a heterogeneous mutational landscape
por: Subbiah, Ishwaria M., et al.
Publicado: (2017) -
Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets
por: Roszik, Jason, et al.
Publicado: (2019)